Clarenta

Planning an oncology trial means understanding the patients you need to reach, the sites that can support them and the practical demands of your protocol. Those considerations also need to inform the development decisions made before the clinic. At Clarenta, we bring experience from supporting more than 150 oncology studies to our work with biotech and pharma teams. We connect non-clinical and CMC planning, regulatory strategy and early phase study design with clinical delivery across Europe, keeping your wider development programme in view. Let’s discuss how we can support your next oncology milestone ➡️https://lnkd.in/dpUPvs4a

Comac Medical Group is now Clarenta! A new name and identity for the company we have become. Over nearly three decades, our capabilities and our role in clinical development have expanded. Clarenta represents how we connect strategic thinking, scientific insight and operational delivery to help biotech and pharma sponsors make informed decisions. It also reflects how we work: asking the right questions early, anticipating risks and communicating openly. Hear our story as our CEO, Chris Smyth, shares what brought us here and the direction we are taking next. Our name has changed. Our people, expertise, relationships and commitment to quality remain. Welcome to #Clarenta ➡️ www.clarenta.com

🎥 Meet Chris Smyth, Group CEO of #ComacMedical, and the leader shaping our next chapter. With more than 30 years of experience across CROs and biotech, Chris brings a leadership style grounded in curiosity, collaboration, and resilience. In this first video of our three-part CEO interview series, Chris reflects on his professional journey, the leadership lessons that shaped him, and what continues to inspire his work in clinical research. 𝐆𝐞𝐭 𝐭𝐨 𝐤𝐧𝐨𝐰 𝐭𝐡𝐞 𝐩𝐞𝐫𝐬𝐨𝐧 𝐛𝐞𝐡𝐢𝐧𝐝 𝐭𝐡𝐞 𝐂𝐄𝐎 𝐭𝐢𝐭𝐥𝐞! 👉 Watch the full interview here: https://lnkd.in/e2VZgQ67 Together with ILIFE CONSULTING, we’re excited about what’s ahead. #Leadership #ClinicalResearch #CEOInterview #Biotech #iLIFECONSULTING

Day 2 at #OCTEurope in Barcelona is in full swing, and the buzz around clinical trial innovation is electric! Our power team, Diana Gheorghi and Martina Forte, are at Booth #50, diving deep into the future of clinical outsourcing and ready to forge impactful partnerships. ✨ The best part of being here? The real conversations. We’re hearing first-hand about the hurdles sponsors are facing and sharing how we tackle those complexities every day. This isn’t just networking: it’s where the next generation of clinical strategy is actually being built. 👋 Stop by Booth #50 to say hello. Let’s turn today’s discussions into tomorrow’s clinical successes! If you didn’t get a chance to connect with Diana and Martina in person, let’s continue the conversation 👉 https://lnkd.in/diWYZ5wG Outsourcing in Clinical Trials Event Series #ClinicalTrials #ComacMedical #OCTEurope26 #OCT

Our incredible team was at #BioEquity Europe in Prague this week to dive deep into these industry shifts and connect with the leaders driving the next wave of breakthroughs 🚀 Isidora Isakov and Biljana Stuparevic, our Business Development Directors, joined the global biotech community to discuss the most pressing challenges and opportunities in clinical development. 📹 In the video below, they share insights directly from the event floor. While funding remains a hurdle, the level of innovation we’ve seen from the global biotech community this week is truly impressive. This resilience fuels our commitment to delivering smarter and more adaptive clinical solutions for our partners. A huge thank you to everyone who connected with Isidora and Biljana! If you didn’t have a chance to meet them in person, let’s continue the conversation 👉 https://lnkd.in/d8k9tvRT BioCentury Inc. #ComacMedical #BioEquityEurope #Biopharma #BiotechInnovation

🎯 Choosing the right CRO can be one of the most critical decisions a biotech company makes. In this month’s edition of 𝐓𝐡𝐞 𝐂𝐑𝐎-𝐧𝐢𝐜𝐥𝐞 𝐨𝐟 𝐓𝐫𝐢𝐚𝐥𝐬, we explore the key factors biotech companies should consider when selecting a CRO partner, including: 🔹 Therapeutic and phase-specific experience 🔹 Operational agility and a collaborative working model 🔹 Regulatory expertise and global compliance 🔹 Site access and patient recruitment capabilities 🔹 Technology, data transparency, and financial predictability 📘 Read the full article now 👇 #ComacMedical #Biotech #ClinicalTrials #ClinicalResearch